Outcome of patients with ≥70% symptomatic intracranial stenosis after wingspan stenting

Stroke

Volumn 42, Issue 7, 2011, Pages 1971-1975

  Jiang, Wei Jian ^a,b   Yu, Wengui ^c   Du, Bin ^a   Gao, Feng ^a   Cui, Li Ying ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

angioplasty and stenting; atherosclerosis; intracranial stenosis; outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; BRAIN ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPOTHESIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT; SYMPTOM; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY STENOSIS; WINGSPAN STENTING;

ADOLESCENT; ADULT; AGED; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; COHORT STUDIES; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; STENTS; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 79959969831     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.595926     Document Type: Article

References (13)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352: 1305-1316.
2. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
3. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Lynn MJ, Chimowitz M; for the NIH Multi-center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524. (Pubitemid 351589505)
4. Bose A, Hartmann M, Henkes H, Liu HM, Teng MMH, Szikora I, Berlis A, Reul J, Yu SCH, Forsting M, Lui M, Lim W, Sit SP. A novel, selfexpanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38:1531-1537. (Pubitemid 46684170)
5. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881-887. (Pubitemid 46568447)
6. Fiorella D, Turan TN, Derdeyn CP, Chimowitz MI. Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting. J Neurointerv Surg. 2009;1:35-39.
7. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420-426. (Pubitemid 46208744)
8. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643-646. (Pubitemid 30210425)
9. Gao F, Du B, Xu XT, Wang YJ, Jiang WJ. Safety of low-dose heparin for intracranial stent-assisted angioplasty: a randomized controlled pilot study. J Endovasc Ther. 2009;16:642-648.
10. Jiang WJ, Du B, Hon SFK, Jin M, Xu XT, Ma N, Gao F, Dong KH. Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting? J Neurointervent Surg. 2010;2:50-54.
11. Wong KS, Li H, Chan YL, Ahuja A, Lam WWM, Wong A, Kay R. Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke. 2000;31:2641-2647.
12. Kurre W, Berkefeld J, Brassel F, Bruning R, Eckert B, Kamek S, Klein GE, Knauth M, Liebig T, Maskova J, Mucha D, Neumann-Haefelin T, Pilgram-Pastor S, Sitzer M, Sonnberger M, Tietke M, Trenkler J, Turowski B; for the INTRASTENT Study Group. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke. 2010; 41:494-498.
13. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI; for the WASID trial investigators. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068. (Pubitemid 350175708)